Clinical Trial Update: Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk [Phase 4]

View source ↗

Summary

A Phase 4 trial compares high-dose fluvastatin monotherapy (80 mg) to combination therapy with ezetimibe (10 mg) in patients at high cardiovascular risk with hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Fluvastatin (fluvastatin)

Snippet

Sponsor: Medical University of Graz | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED